Hutch News
Results per Page:
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
Measure 170 times, cut once: high-throughput drug screening for multiple myeloma
From Dr. Pamela Becker and Dr. David Coffey, Clinical Research Division
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Tip Sheet: Looking ahead to 2021, COVID-19 vaccines, improving health outcomes — and more
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Seeking targeted treatments for pancreatic cancer
American Cancer Society fellowship to Dr. Nithya Kartha supports search for vulnerabilities in most aggressive pancreatic tumor subtype
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion
A path opens for precise analyses of breast cancer proteins
Paulovich lab runs CLIA-cleared tests to find patients appropriate for new HER2-targeted therapies
Immune response in colorectal cancer: What helps, what hurts?
GECCO collaboration drills into mechanisms of specific T-cell response to germline variations, lifetime exposures and tumor environment
2 Fred Hutch leaders receive PSBJ Health Care Leadership Awards
Puget Sound Business Journal honors Drs. Gary Gilliland, Nancy Davidson among 16 regional health care leaders
New insights into advanced bladder cancer
First-of-its-kind rapid autopsy program helps reveal deadly disease’s potential vulnerabilities
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
Path to a targeted treatment for small-cell lung cancer?
Researchers show how common mutation in SCLC makes mouse tumors more vulnerable to certain cancer drugs
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Functional genomics pinpoints unique tumor vulnerabilities
Technique pinpoints unique tumor vulnerabilities — even when they are not written in tumor DNA
Early phase clinical trial shows promise for advanced head and neck cancer
Nine out of 10 patients treated with the experimental therapy saw their tumors shrink
MERGE improves precision medicine for acute myeloid leukemia
from Dr. Pamela Becker, Clinical Research Division